![]()
13
| 4 | 2009
Klinisk Biokemi i Norden
regulation of postnatal anti-Müllerian hor-
mone secretion by Sertoli cells. Trends Endo-
crinol Metab 1998; 9: 271-6.
13. di Clemente N, Belville C. Anti-Müllerian
hormone receptor defect. Best Pract Res Clin
Endocrinol Metab 2006; 20: 599-610.
14. Cohen-Haguenauer O, Picard JY, Mattéi MG,
Serero S, Nguyen VC, de Tand MF, Guerrier
D, Hors-Cayla MC, Josso N, Frézal J. Map-
ping of the gene for anti-müllerian hormone
to the short arm of human chromosome 19.
Cytogenet Cell Genet 1987; 44: 2-6.
15. Pepinsky RB, Sinclair LK, Chow EP, Matta-
liano RJ, Manganaro TF, Donahoe PK, Cate
RL. Proteolytic processing of Mullerian inhi-
biting substance produces a transforming
growth factor-β-like fragment. J Biol Chem
1988; 263:18961-4.
16. Wilson CA, di Clemente N, Ehrenfels C,
Pepinsky RB, Josso N, Vigier B, Cate RL.
Mullerian inhibiting substance requires its
N-terminal domain for maintenance of bio-
logical activity, a novel finding within the
transforming growth factor-beta superfamily.
Mol Endocrinol 1993; 7: 247-57.
17. Streuli I, Fraisse T, Chapron C, Bijaoui G,
Bischof P, de Ziegler D. Clinical uses of anti-
Müllerian hormone assays: pitfalls and pro-
mises. Fertil Steril 2009; 91: 226-30.
18. Fréour T, Mirallié S, Bach-Ngohou K, Denis
M, Barrière P, Masson D. Measurement of
serum anti-Müllerian hormone by Beckman
Coulter ELISA and DSL ELISA: Comparison
and relevance in assisted reproduction tech-
nology (ART). Clin Chim Acta 2007; 375:
162-4.
19. Bersinger NA, Wunder D, Birkhäuser MH,
Guibourdenche J. Measurement of anti-mul-
lerian hormone by Beckman Coulter ELISA
and DSL ELISA in assisted reproduction: dif-
ferences between serum and follicular fluid.
Clin Chim Acta 2007; 384: 174-5.
20. Al-Qahtani A, Groome NP. Editorial: Anti-
Müllerian hormone: Cinderella finds new
admirers. J Clin Endocrinol Metab 2006; 91:
3760-2.
21. Visser JA, Themmen APN. Anti-Müllerian
hormone and folliculogenesis. Mol Cell
Endocrinol 2005; 234: 81-6.
22. Hehenkamp WJK, Looman CWN, Themmen
APN, de Jong FH, te Velde ER, Broekmans
FJM. Anti-Müllerian hormone levels in the
spontaneous menstrual cycle do not show
substantial fluctuation. J Clin Endocrinol
Metab 2006; 91: 4057-63.
23. Muttukrishna S, Suharjono H, McGarrigle H,
Sathanandan M. Inhibin B and anti-Mulle-
rian hormone: markers of ovarian response in
IVF/ICSI patients? BJOG 2004; 111: 1248-53.
24. Lee T-H, Liu C-H, Huang C-C, Wu Y-L, Shih
Y-T, Ho H-N, Yang Y-S, Lee M-S. Serum anti-
müllerian hormone and estradiol levels as
predictors of ovarian hyperstimulation syn-
drome in assisted reproduction technology
cycles. Hum Reprod 2008; 23: 160-7.
25. Laven JSE, Mulders AGMGJ, Visser JA,
Themmen AP, de Jong FH, Fauser BCJM.
Anti-Müllerian hormone serum concentra-
tions in normoovulatory and anovulatory
women of reproductive age. J Clin Endocrinol
Metab 2004; 89: 318-23.
26. La Marca A, Volpe A. The Anti-Müllerian
hormone and ovarian cancer. Hum Reprod
Update 2007; 13: 265-73.
27. Partridge AH, Ruddy KJ, Gelber S, Schapira
L, Abusief M, Meyer M, Ginsburg E. Ovarian
reserve in women who remain premenopau-
sal after chemotherapy for early stage breast
cancer. Fertil Steril 2009 (in press).
28. Broekmans FJ, Visser JA, Laven JSE, Broer SL,
Themmen APN, Fauser BC. Anti-Müllerian
hormone and ovarian dysfunction. Trends
Endocrinol Metab 2008; 19: 340-7.
29. Teixeira J, Maheswaran S, Donahoe PK. Mül-
lerian inhibiting substance: an instructive
developmental hormone with diagnostic and
possible therapeutic applications. Endocr Rev
2001; 22: 657-74.
